Asian Pacific Journal of Cancer Prevention

  • 제13권3호
  • /
  • Pages.891-896
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Human Papillomavirus Infection and Prognostic Predictors in Patients with Oropharyngeal Squamous Cell Carcinoma

  • Huang, Hui (Department of Head and Neck Surgery, Cancer Hospital) ;
  • Zhang, Bin (Department of Head and Neck Surgery, Cancer Hospital) ;
  • Chen, Wen (Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College) ;
  • Zhou, Shuang-Mei (Department of Pathology, Cancer Hospital) ;
  • Zhang, Yong-Xia (Department of Head and Neck Surgery, Cancer Hospital) ;
  • Gao, Li (Department of Radiation Oncology, Cancer Hospital) ;
  • Xu, Zhen-Gang (Department of Head and Neck Surgery, Cancer Hospital) ;
  • Qiao, You-Lin (Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College) ;
  • Tang, Ping-Zhang (Department of Head and Neck Surgery, Cancer Hospital)
  • 발행 : 2012.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study focused on infection rates and subtypes of human papillomavirus (HPV) in patients with oropharyngeal squamous cell carcinoma (OSCC), and the relationship between HPV status and prognosis of the disease. We evaluated sixty-six OSCC patients who met the enrollment criteria during the period from January 1999 to December 2009. The presence or absence of oncogenic HPV types in tumors was determined using the SPF10 LiPA25 assay. Overall survival (OS) and disease specific survival (DSS) for HPV positive and HPV negative patients were estimated using Kaplan-Meier analysis. The Cox regression model was applied for multivariate analysis. HPV-DNA was detected in 11(16.7%) of all specimens. Among them, 7 were type HPV-16, while other types were HPV-16/11, HPV-35, HPV-58/52, and HPV-33/52/54. Patients with HPV positive tumors were more likely to be female, non-smokers and non-drinkers (p=0.002, 0.001 and 0.001, respectively). After a median follow-up of 24.5 months, patients with HPV positive tumors had significantly better overall survival (HR=0.106[95%CI=0.014-0.787], p=0.016,) and disease specific survival (HR=0.121[95%CI=0.016-0.906], p=0.030). Patients with HPV positive OSCC have significantly better prognosis than patients with HPV negative tumors. HPV infection is an independent prognostic factor.

키워드

참고문헌

  1. Andrews E, Seaman WT, Webster-Cyriaque J (2009). Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Oral Oncol, 45, 486-91. https://doi.org/10.1016/j.oraloncology.2008.07.008
  2. Chen W, Zhang X, Molijn A, et al (2009). Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control, 20, 1705-13. https://doi.org/10.1007/s10552-009-9422-z
  3. D'Souza G, Kreimer AR, Viscidi R, et al (2007). Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 356, 1944-56. https://doi.org/10.1056/NEJMoa065497
  4. Dayyani F, Etzel CJ, Liu M, et al (2010). Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol, 2, 15. https://doi.org/10.1186/1758-3284-2-15
  5. Fakhry C, Westra WH, Li S, et al (2008). Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst, 100, 261-9. https://doi.org/10.1093/jnci/djn011
  6. Gillison ML, D'Souza G, Westra W, et al (2008). Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst, 100, 407-20. https://doi.org/10.1093/jnci/djn025
  7. Gillison ML, Koch WM, Capone RB, et al (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst, 92, 709-20. https://doi.org/10.1093/jnci/92.9.709
  8. Hafkamp HC, Manni JJ, Haesevoets A, et al (2008). Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer, 122, 2656-64. https://doi.org/10.1002/ijc.23458
  9. Herrero R, Castellsague X, Pawlita M, et al (2003). Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst, 95, 1772-83. https://doi.org/10.1093/jnci/djg107
  10. Hong AM, Dobbins TA, Lee CS, et al (2010). Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer, 103, 1510-7. https://doi.org/10.1038/sj.bjc.6605944
  11. Joo YH, Jung CK, Sun DI, et al (2011). High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer. Head Neck.
  12. Kleter B, van Doorn LJ, Schrauwen L, et al (1999). Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol, 37, 2508-17.
  13. Klussmann JP, Weissenborn SJ, Wieland U, et al (2001). Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer, 92, 2875-84. https://doi.org/10.1002/1097-0142(20011201)92:11<2875::AID-CNCR10130>3.0.CO;2-7
  14. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev, 14, 467-75. https://doi.org/10.1158/1055-9965.EPI-04-0551
  15. Kumar B, Cordell KG, Lee JS, et al (2007). Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys, 69, S109-11.
  16. Kuo KT, Hsiao CH, Lin CH, et al (2008). The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol, 21, 376-86. https://doi.org/10.1038/modpathol.3800979
  17. Licitra L, Perrone F, Bossi P, et al (2006). High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol, 24, 5630-6. https://doi.org/10.1200/JCO.2005.04.6136
  18. Lill C, Kornek G, Bachtiary B, et al (2011). Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced. Wien Klin Wochenschr, 123, 215-21. https://doi.org/10.1007/s00508-011-1553-z
  19. Mak-Kregar S, Hilgers FJ, Levendag PC, et al (1995). A nationwide study of the epidemiology, treatment and survival of oropharyngeal carcinoma in The Netherlands. Eur Arch Otorhinolaryngol, 252, 133-8. https://doi.org/10.1007/BF00178098
  20. Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27. https://doi.org/10.1056/NEJMoa021641
  21. Nasman A, Attner P, Hammarstedt L, et al (2009). Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer, 125, 362-6. https://doi.org/10.1002/ijc.24339
  22. Posner MR, Lorch JH, Goloubeva O, et al (2011). Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol, 22, 1071-7. https://doi.org/10.1093/annonc/mdr006
  23. Shiboski CH, Schmidt BL, Jordan RC (2005). Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer, 103, 1843-9. https://doi.org/10.1002/cncr.20998
  24. Smith EM, Ritchie JM, Summersgill KF, et al (2004). Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer, 108, 766-72. https://doi.org/10.1002/ijc.11633
  25. St Guily JL, Jacquard AC, Pretet JL, et al (2011). Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study. J Clin Virol, 51, 100-4. https://doi.org/10.1016/j.jcv.2011.03.003
  26. Tachezy R, Klozar J, Rubenstein L, et al (2009). Demographic and risk factors in patients with head and neck tumors. J Med Virol, 81, 878-87. https://doi.org/10.1002/jmv.21470
  27. Weinberger PM, Yu Z, Haffty BG, et al (2006). Molecular classification identifies a subset of human papillomavirus-- associated oropharyngeal cancers with favorable prognosis. J Clin Oncol, 24, 736-47. https://doi.org/10.1200/JCO.2004.00.3335
  28. Worden FP, Kumar B, Lee JS, et al (2008). Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol, 26, 3138-46. https://doi.org/10.1200/JCO.2007.12.7597

피인용 문헌

  1. Increase in the Rate of HPV Positive Oropharyngeal Cancers During 1996-2011 in a Case Study in Turkey vol.14, pp.10, 2013, https://doi.org/10.7314/APJCP.2013.14.10.6065
  2. Epigenetic Mechanisms in Penile Carcinoma vol.14, pp.6, 2013, https://doi.org/10.3390/ijms140610791
  3. Predictive value of human papillomavirus in oropharyngeal carcinoma treated with radiotherapy: An updated systematic review and meta-analysis of 30 trials vol.36, pp.5, 2013, https://doi.org/10.1002/hed.23351
  4. Lack of Association between High-risk Human Papillomaviruses and Oral Squamous Cell Carcinoma in Young Japanese Patients vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4135
  5. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma vol.33, pp.1, 2014, https://doi.org/10.1186/s13046-014-0100-y
  6. Significance of p16 Positive Expression in Oropharyngeal Cancers vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10289
  7. Expression and Response to Therapy and Survival in Selected Head and Neck Cancers vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.253
  8. A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer vol.33, pp.6, 2015, https://doi.org/10.1007/s10637-015-0293-8
  9. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population vol.11, pp.10, 2016, https://doi.org/10.1371/journal.pone.0164491
  10. Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy vol.12, pp.1, 2017, https://doi.org/10.1371/journal.pone.0170091